Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: A4H8Z9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 167 | 171 | PF00656 | 0.668 |
CLV_NRD_NRD_1 | 10 | 12 | PF00675 | 0.681 |
CLV_NRD_NRD_1 | 58 | 60 | PF00675 | 0.788 |
CLV_NRD_NRD_1 | 85 | 87 | PF00675 | 0.557 |
CLV_PCSK_KEX2_1 | 10 | 12 | PF00082 | 0.681 |
CLV_PCSK_KEX2_1 | 58 | 60 | PF00082 | 0.725 |
CLV_PCSK_KEX2_1 | 85 | 87 | PF00082 | 0.591 |
CLV_PCSK_SKI1_1 | 132 | 136 | PF00082 | 0.661 |
CLV_PCSK_SKI1_1 | 215 | 219 | PF00082 | 0.529 |
DOC_MAPK_gen_1 | 58 | 64 | PF00069 | 0.717 |
DOC_PP2B_LxvP_1 | 6 | 9 | PF13499 | 0.796 |
DOC_PP2B_LxvP_1 | 76 | 79 | PF13499 | 0.537 |
DOC_USP7_MATH_1 | 12 | 16 | PF00917 | 0.659 |
DOC_USP7_MATH_1 | 47 | 51 | PF00917 | 0.768 |
DOC_USP7_MATH_1 | 87 | 91 | PF00917 | 0.701 |
DOC_WW_Pin1_4 | 77 | 82 | PF00397 | 0.695 |
LIG_14-3-3_CanoR_1 | 10 | 20 | PF00244 | 0.767 |
LIG_14-3-3_CanoR_1 | 139 | 148 | PF00244 | 0.639 |
LIG_14-3-3_CanoR_1 | 156 | 164 | PF00244 | 0.716 |
LIG_14-3-3_CanoR_1 | 215 | 220 | PF00244 | 0.528 |
LIG_14-3-3_CanoR_1 | 85 | 95 | PF00244 | 0.705 |
LIG_Actin_WH2_2 | 24 | 40 | PF00022 | 0.747 |
LIG_Actin_WH2_2 | 45 | 60 | PF00022 | 0.599 |
LIG_BRCT_BRCA1_1 | 141 | 145 | PF00533 | 0.638 |
LIG_deltaCOP1_diTrp_1 | 190 | 197 | PF00928 | 0.648 |
LIG_FHA_1 | 64 | 70 | PF00498 | 0.562 |
LIG_GBD_Chelix_1 | 140 | 148 | PF00786 | 0.734 |
LIG_LIR_Gen_1 | 122 | 128 | PF02991 | 0.496 |
LIG_LIR_Nem_3 | 122 | 127 | PF02991 | 0.496 |
LIG_LIR_Nem_3 | 142 | 148 | PF02991 | 0.612 |
LIG_LIR_Nem_3 | 170 | 176 | PF02991 | 0.647 |
LIG_MYND_3 | 198 | 202 | PF01753 | 0.731 |
LIG_NRBOX | 15 | 21 | PF00104 | 0.661 |
LIG_PCNA_PIPBox_1 | 137 | 146 | PF02747 | 0.749 |
LIG_PCNA_yPIPBox_3 | 10 | 20 | PF02747 | 0.667 |
LIG_Pex14_1 | 193 | 197 | PF04695 | 0.640 |
LIG_Rb_pABgroove_1 | 139 | 147 | PF01858 | 0.641 |
LIG_SH2_CRK | 176 | 180 | PF00017 | 0.472 |
LIG_SH2_SRC | 183 | 186 | PF00017 | 0.512 |
LIG_SH2_STAT5 | 27 | 30 | PF00017 | 0.651 |
LIG_SH3_3 | 20 | 26 | PF00018 | 0.650 |
LIG_TRAF2_1 | 128 | 131 | PF00917 | 0.744 |
LIG_TRAF2_1 | 165 | 168 | PF00917 | 0.700 |
MOD_CK2_1 | 104 | 110 | PF00069 | 0.527 |
MOD_CK2_1 | 162 | 168 | PF00069 | 0.706 |
MOD_CK2_1 | 86 | 92 | PF00069 | 0.710 |
MOD_GlcNHglycan | 151 | 154 | PF01048 | 0.654 |
MOD_GlcNHglycan | 180 | 183 | PF01048 | 0.746 |
MOD_GlcNHglycan | 2 | 5 | PF01048 | 0.630 |
MOD_GlcNHglycan | 49 | 52 | PF01048 | 0.771 |
MOD_GlcNHglycan | 89 | 92 | PF01048 | 0.722 |
MOD_NEK2_2 | 171 | 176 | PF00069 | 0.739 |
MOD_PIKK_1 | 80 | 86 | PF00454 | 0.814 |
MOD_ProDKin_1 | 77 | 83 | PF00069 | 0.697 |
MOD_SUMO_rev_2 | 110 | 120 | PF00179 | 0.752 |
MOD_SUMO_rev_2 | 125 | 134 | PF00179 | 0.570 |
TRG_DiLeu_BaEn_4 | 130 | 136 | PF01217 | 0.661 |
TRG_DiLeu_BaLyEn_6 | 15 | 20 | PF01217 | 0.532 |
TRG_ENDOCYTIC_2 | 124 | 127 | PF00928 | 0.658 |
TRG_ENDOCYTIC_2 | 176 | 179 | PF00928 | 0.732 |
TRG_ER_diArg_1 | 57 | 59 | PF00400 | 0.779 |
TRG_ER_diArg_1 | 9 | 11 | PF00400 | 0.784 |
TRG_NES_CRM1_1 | 146 | 161 | PF08389 | 0.770 |
TRG_NES_CRM1_1 | 196 | 209 | PF08389 | 0.613 |
TRG_Pf-PMV_PEXEL_1 | 18 | 22 | PF00026 | 0.526 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I6A6 | Leptomonas seymouri | 64% | 79% |
A0A3S5H706 | Leishmania donovani | 82% | 100% |
A4HXD0 | Leishmania infantum | 81% | 100% |
E9AR25 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 81% | 100% |
Q4QED8 | Leishmania major | 81% | 100% |